| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |